Celecoxib-related renal papillary necrosis

Arch Intern Med. 2003 Jan 13;163(1):114-5. doi: 10.1001/archinte.163.1.114.

Abstract

Selective cyclooxygenase 2 (COX-2) inhibitors are known to affect renal prostaglandins (epoprostenol and dinoprostone), which are at least in part COX-2 dependent. Consequently, adverse events including hypertension, peripheral edema, hypercalemia, hyponatremia, and acute renal failure have been reported to occur with the new COX-2-specific inhibitors. This case report posits celecoxib as a likely cause of renal papillary necrosis and alerts physicians to the possibility of this additional renal complication with COX-2-specific inhibitors.

Publication types

  • Case Reports

MeSH terms

  • Arthritis, Rheumatoid / drug therapy
  • Celecoxib
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / administration & dosage
  • Cyclooxygenase Inhibitors / adverse effects*
  • Female
  • Humans
  • Isoenzymes / antagonists & inhibitors*
  • Kidney Papillary Necrosis / chemically induced*
  • Kidney Papillary Necrosis / diagnostic imaging
  • Kidney Papillary Necrosis / enzymology
  • Membrane Proteins
  • Middle Aged
  • Prostaglandin-Endoperoxide Synthases
  • Pyrazoles
  • Sulfonamides / administration & dosage
  • Sulfonamides / adverse effects*
  • Urography

Substances

  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • Pyrazoles
  • Sulfonamides
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Celecoxib